Related Experiment Video

Updated: May 22, 2026

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia
07:48

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia

Published on: June 8, 2019

Insights into gene therapy for critical limb ischemia: the devil is in the details

Rosalinda Madonna1, Gregg Rokosh

  • 1Institute of Cardiology, "G. D'Annunzio" University, Chieti, Italy.

Vascular Pharmacology
|May 15, 2012
PubMed

Insights

Gene therapy using angiogenic factors shows promise for critical limb ischemia (CLI) patients lacking revascularization options. Hepatic growth factor (HGF) gene therapy has demonstrated the most success in preventing amputation and improving patient outcomes.

Area of Science:

  • Vascular biology and regenerative medicine
  • Gene therapy applications in cardiovascular disease

Background:

  • Critical limb ischemia (CLI) poses a significant risk of amputation and mortality for patients unresectable by traditional revascularization methods.
  • Current therapeutic options for CLI patients without revascularization potential are limited.

Purpose of the Study:

  • To review and analyze the efficacy of gene therapy utilizing various angiogenic factors for treating CLI.
  • To identify the most successful gene therapy approaches for improving CLI patient outcomes.

Main Methods:

  • Review of clinical trial data for gene therapies targeting angiogenesis in CLI.
  • Analysis of outcomes including amputation rates, mortality, pain reduction, wound healing, and blood flow.
  • Focus on trials involving hepatic growth factor (HGF), vascular endothelial growth factor (VEGF), and basic fibroblast growth factor (bFGF).

Main Results:

  • Gene therapy trials for CLI have yielded variable results.
  • Hepatic growth factor (HGF) gene therapy has shown the most promising success in clinical trials.
  • Angiogenic factors aim to improve blood flow, promote healing, and reduce pain in CLI patients.

Conclusions:

  • Gene therapy represents a potential therapeutic avenue for CLI patients ineligible for revascularization.
  • Further research into angiogenic factors, particularly HGF, is warranted to optimize treatment strategies.
  • Insights from recent studies will guide the development of more effective gene-based therapies for CLI.

More Related Videos

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits07:34

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits

Published on: June 2, 2019

A Modified Surgical Model of Hind Limb Ischemia in ApoE-/- Mice using a Miniature Incision05:47

A Modified Surgical Model of Hind Limb Ischemia in ApoE-/- Mice using a Miniature Incision

Published on: May 13, 2021

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...